Poseidon Platinum 3500 capsule — Class I drug recall D-0654-2021
Terminated recall by Yamtun7, reported 2021-07-21. Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making the
| Recall number | D-0654-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Yamtun7, Delray Beach, FL, United States |
| Recall initiated | 2021-05-11 |
| Classified | 2021-07-12 |
| Reported by FDA | 2021-07-21 |
| Terminated | 2023-07-12 |
| Quantity | 36 capsules |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00095842058760 |
Product
Poseidon Platinum 3500 capsule, 1-count per blister card, Distributed by: Poseidon, Made in the USA, UPC 0 95842 05876 0
Reason for recall
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0654-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.